Abstract
Women who carry mutations in the BRCA1 gene on chromosome 17q have an 85% lifetime risk of breast cancer, and a 60% risk of ovarian cancer. We have identified BRCA1 mutations in 12 of 30 (40%) Canadian families with breast and/or ovarian cancer, including six of the eight families (75%) that contained two cases of early-onset breast cancer and two cases of ovarian cancer. Six frameshift mutations account for all 12 mutant alleles, including nucleotide insertions (two mutations) and deletions (four mutations). Four independent families carried the same 1 basepair (bp) insertion mutation in codon 1755 and four other families shared a 2 bp deletion mutation in codons 22–23. These families were not known to be related, but haplotype analysis suggests that the carriers of each of these mutations have common ancestors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hall, J.M. et al. Linkage analysis of early onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).
Narod, S.A. et al. Familial breast-ovarian cancer locus on chromosome 17q12–23. Lancet 338, 82–83 (1991).
Miki, Y. et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Narod, S.A. et al. A heterogeneity analysis of 145 breast-ovarian cancer families. Am. J. hum. Genet. (in the press).
Tonin, P. et al. Linkage analysis of 26 Canadian breast and breast-ovarian cancer families. Hum. Genet. (in the press).
Goldgar, D.E. et al. A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic and genealogic analysis. J. natn. Cancer Inst. 86, 200–209 (1994).
Neuhausen, S.L. et al. A P1-based physical map of the BRCA1 region from D17S766 to D17S78. Hum. molec. Genet. 3, 1919–1926 (1994).
Wooster, R. et al. Localization of a breast cancer susceptibility, BRCA2, to chromosome 13q12–13. Science 265, 2088–2090 (1994).
Futreal, P.A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120–122 (1994).
Feunteun, J. et al. A breast cancer susceptibility gene maps to chromosome 17q21. Am. J. hum. Genet. 52, 736–743 (1993).
Easton, D.F. et al. Genetic linkage analysis in familial breast and ovarian cancer & results from 214 families. Am. J. hum. Genet. 52, 678–701 (1993).
Simard, J. et al. Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q–21; exclusion of candidate genes EDH17B2 and RARA. Hum. molec. Genet. 2, 1193–1199 (1993).
Anderson, L. et al. High density genetic map of the BRCA1 region of chromosome 17q–q21. Genomics 17, 618–623 (1993).
Beaudet, A.L. & Tsui, L.-C. A suggested nomenclature for designating mutations. Hum. Mutation 2, 245–248 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simard, J., Tonin, P., Durocher, F. et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8, 392–398 (1994). https://doi.org/10.1038/ng1294-392
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1294-392